Use of a Rapid HIV Home Test to Screen Sexual Partners: A Commentary on Ventuneac, Carballo-Diéguez, Leu et al. 2009
Abstract Previously, we estimated the HIV risk reduction that men who have sex with men could attain using a rapid HIV home test to screen sexual partners versus using condoms inconsistently. Here, we clarify the assumptions of our published formulas. Using models that more closely resemble our study population, our results show a difference from that presented in the original article in the magnitude of the relative advantage (i.e., lower risk of HIV infection) for HIV home test use versus inconsistent condom use. We present a general formula that can accommodate different types of partnerships in estimating risk of HIV infection..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2011 |
---|---|
Erschienen: |
2011 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
Aids and behavior - 16(2011), 1 vom: 08. Apr., Seite 1-4 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Leu, Cheng-Shiun [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
BKL: | |
---|---|
Themen: |
Gay men |
Anmerkungen: |
© Springer Science+Business Media, LLC 2011 |
---|
doi: |
10.1007/s10461-011-9920-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2110984171 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | OLC2110984171 | ||
003 | DE-627 | ||
005 | 20230502195159.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230502s2011 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10461-011-9920-3 |2 doi | |
035 | |a (DE-627)OLC2110984171 | ||
035 | |a (DE-He213)s10461-011-9920-3-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.78$jImmunkrankheiten |2 bkl | ||
100 | 1 | |a Leu, Cheng-Shiun |e verfasserin |4 aut | |
245 | 1 | 0 | |a Use of a Rapid HIV Home Test to Screen Sexual Partners: A Commentary on Ventuneac, Carballo-Diéguez, Leu et al. 2009 |
264 | 1 | |c 2011 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © Springer Science+Business Media, LLC 2011 | ||
520 | |a Abstract Previously, we estimated the HIV risk reduction that men who have sex with men could attain using a rapid HIV home test to screen sexual partners versus using condoms inconsistently. Here, we clarify the assumptions of our published formulas. Using models that more closely resemble our study population, our results show a difference from that presented in the original article in the magnitude of the relative advantage (i.e., lower risk of HIV infection) for HIV home test use versus inconsistent condom use. We present a general formula that can accommodate different types of partnerships in estimating risk of HIV infection. | ||
650 | 4 | |a Probability of HIV transmission | |
650 | 4 | |a Serosorting | |
650 | 4 | |a Risk reduction for HIV | |
650 | 4 | |a Gay men | |
650 | 4 | |a Men who have sex with men | |
700 | 1 | |a Ventuneac, Ana |4 aut | |
700 | 1 | |a Levin, Bruce |4 aut | |
700 | 1 | |a Carballo-Diéguez, Alex |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Aids and behavior |d Springer US, 1997 |g 16(2011), 1 vom: 08. Apr., Seite 1-4 |h Online-Ressource |w (DE-627)320523144 |w (DE-600)2014832-X |w (DE-576)121191214 |x 1573-3254 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2011 |g number:1 |g day:08 |g month:04 |g pages:1-4 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10461-011-9920-3 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_32 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_90 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_100 | ||
912 | |a GBV_ILN_101 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_120 | ||
912 | |a GBV_ILN_138 | ||
912 | |a GBV_ILN_150 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_187 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_370 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_636 | ||
912 | |a GBV_ILN_702 | ||
912 | |a GBV_ILN_2001 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2004 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2007 | ||
912 | |a GBV_ILN_2008 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a GBV_ILN_2020 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_2025 | ||
912 | |a GBV_ILN_2026 | ||
912 | |a GBV_ILN_2027 | ||
912 | |a GBV_ILN_2031 | ||
912 | |a GBV_ILN_2034 | ||
912 | |a GBV_ILN_2037 | ||
912 | |a GBV_ILN_2038 | ||
912 | |a GBV_ILN_2039 | ||
912 | |a GBV_ILN_2044 | ||
912 | |a GBV_ILN_2048 | ||
912 | |a GBV_ILN_2049 | ||
912 | |a GBV_ILN_2055 | ||
912 | |a GBV_ILN_2057 | ||
912 | |a GBV_ILN_2059 | ||
912 | |a GBV_ILN_2061 | ||
912 | |a GBV_ILN_2064 | ||
912 | |a GBV_ILN_2065 | ||
912 | |a GBV_ILN_2068 | ||
912 | |a GBV_ILN_2070 | ||
912 | |a GBV_ILN_2086 | ||
912 | |a GBV_ILN_2088 | ||
912 | |a GBV_ILN_2093 | ||
912 | |a GBV_ILN_2106 | ||
912 | |a GBV_ILN_2107 | ||
912 | |a GBV_ILN_2108 | ||
912 | |a GBV_ILN_2110 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_2112 | ||
912 | |a GBV_ILN_2113 | ||
912 | |a GBV_ILN_2116 | ||
912 | |a GBV_ILN_2118 | ||
912 | |a GBV_ILN_2119 | ||
912 | |a GBV_ILN_2122 | ||
912 | |a GBV_ILN_2129 | ||
912 | |a GBV_ILN_2136 | ||
912 | |a GBV_ILN_2143 | ||
912 | |a GBV_ILN_2144 | ||
912 | |a GBV_ILN_2147 | ||
912 | |a GBV_ILN_2148 | ||
912 | |a GBV_ILN_2152 | ||
912 | |a GBV_ILN_2153 | ||
912 | |a GBV_ILN_2188 | ||
912 | |a GBV_ILN_2190 | ||
912 | |a GBV_ILN_2232 | ||
912 | |a GBV_ILN_2336 | ||
912 | |a GBV_ILN_2446 | ||
912 | |a GBV_ILN_2470 | ||
912 | |a GBV_ILN_2474 | ||
912 | |a GBV_ILN_2507 | ||
912 | |a GBV_ILN_2522 | ||
912 | |a GBV_ILN_2548 | ||
912 | |a GBV_ILN_4035 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4046 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4242 | ||
912 | |a GBV_ILN_4246 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4251 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4326 | ||
912 | |a GBV_ILN_4333 | ||
912 | |a GBV_ILN_4334 | ||
912 | |a GBV_ILN_4335 | ||
912 | |a GBV_ILN_4336 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4393 | ||
912 | |a GBV_ILN_4700 | ||
936 | b | k | |a 44.78$jImmunkrankheiten |q VZ |0 10640945X |0 (DE-625)10640945X |
951 | |a AR | ||
952 | |d 16 |j 2011 |e 1 |b 08 |c 04 |h 1-4 |